APOLLO HOSPITALS ENTER. L vs Bharat Immunological & Biological Corporation Ltd
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and Bharat Immunological & Biological Corporation Ltd (BIBCL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs BIBCL on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability40
- Growth10
- Size & financial health40
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
APOLLOHOSP takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
APOLLOHOSP takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
- − ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
- + ["Stock is trading at 0.87 times its book value"]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 5.09% over past five years.", "Company has a low return on equity of -22.7% over last 3 years.", "Debtor days have increased from 39.6 to 114 days."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.